Evaluation of neuroprotective effect of glucagon-like peptide 1 analogs using neuroimaging
Ashwagandha is acknowledged in numerous pharmacopeias and authoritative references worldwide, including the Ayurvedic Pharmacopoeia of India (API), Indian Pharmacopoeia (IP), British Pharmacopoeia (BP), United States Pharmacopeia (USP), American Herbal Pharmacopoeia (AHP), the Pharmacopoeia of the Peoples Republic of China, and the World Health Organizations monographs [226, 227]
arrow_forward Patients who are a part of the Pazona MD Weight Loss Program have averaged a 20-45 lb weight loss at 3 months
These are called endocrine disruptors
Addiction & Impulse Control Researchers are investigating GLP-1 therapy for its potential in addressing substance use disorders
For example, those who are candidates for Wegovy meet the FDA requirements of having a BMI (body mass index) of 30 or more or 27 or more with a weight-related complication, such as hypertension or [high cholesterol], says Tom Wadden, Ph.D., a psychologist and professor at University of Pennsylvania, in Philadelphia, who studies obesity treatments
